Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RS don't need FINRA approval, but reverse mergers do. That's why they take so long. They probably have good reasons why they don't give much details about this, can't wait to see how this plays out.
Looks like a reverse merger to me, management has not been very clear as to the reasons for the RS. Could be an announcement soon as to why, or not. Doubt if it's an up listing. but something is definitely going on behind the scenes.
- Hopefully never. I never seen any need in it unless there has just been a ton of dilution recently. SS didnt look too bad to me. Nothing here seems to add up. Finra may not even approve it. Anyway according to the next paragraph in the filing looks like they have until the end of this week. Should show up on the daily list soon if it gonna happen.
https://otce.finra.org/otce/dailyList?viewType=Dividends%2FDistributions%2FSplits
Outstanding Shares
622,185,523
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On March 4, 2024, Hallmark Venture Group, Inc. (the “Company”) held a special meeting of shareholders via telephone (the “Special Meeting”). At the Special Meeting, the shareholders approved a proposal to grant the Board of Directors of the Company discretionary authority to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the issued and outstanding shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). Such reverse stock split will combine five hundred (500) outstanding shares of Common Stock, into one share of Common Stock at any time prior to March 31, 2024 (the “Reverse Split Proposal”) resulting in 1,244,371 shares issued and outstanding.
Then why did it sell off to .05 the other day. Sentiment is a huge factor with this one. Still waiting...months. Basically went down, hoping it keeps up.
Should be a huge AH push today. Watch for it to climb pretty fast with the latest excitement. Wouldn't be surprised to see 100% from here after hours today.
Re;
Looks like we have had a lot of folks thinking there would be a PR this morning... Jaguar puts PR's out at 8:30 normally... the PR should come tomorrow not today... it will be tied to the announcement of the AACR presenters tomorrow.
Great post, I have to agree, but I think too many traders are misinformed and they think that Mytesi is only for dogs. But that can work in our favor, because when they find out the real truth of the many applications of this medicine, it could be the catalyst we need.
Look at JANX yesterday they announced their phase 3 trial results on a positive note and the price went up over $52.00 in 2 days!
Volume like that would bust those shorts crying home to mama.
... how many will it take to go from .07 to .50... around 175,000,000 to 200,000,000 ... and there wont be any shorting when that happens...
That 10m @ .05 seems irrational even for conversions. To hold it this long and dump that much at that low price??? Someone got stupid, IMO.
The discord pumpers bring huge volume, if they hit it with JAGX, shorts become buyers! With luck and a lot of help, we could see $1 to $2 who knows may be $10+ near term. Sentiment changes when a stock is going up, & JAGX has a lot going for it, people just don't know???
Day traders are constantly on the hunt for catalysts and momentum, with absolutely NO patience at all. BUT today's trading shows a good amount of interest in JAGX stock, which is good for all of us
That caught my eye too. It's weird but true about how much influence those discord pumpers have
JAGX short term $1.00+ if enough traders come aboard $10.00+ short term. Look at JANX yesterday they announced their phase 3 trial results on a positive note and the price went up over $46.00 in 2 days! When a stock is hot, it's really hot!
Most of the traders that will be buying this, don't know any of the DD that you do. They only buy what's being pumped by the most popular stock influencer at the time. JAGX will have it's day but who knows the high it'll hit???
If it happens that way, then today's prices look really good. Prices on set ups like this usually dip down low before a big run up, and the .05 area is as low as it's gotten so far. Seems that it's all coming to this point, before it runs...not many interested traders before the news, then BAM, suddenly everyone wants it!
RS piss people off, JAGX will get more trading participation running it up from this level. Everyone loves a Cinderella story.
Soon we should be notified of Lisa's decision to make the request or not. But I agree, it would be extremely foolish on her part not to make the request. The company stands to loose much of what they've accomplished, if she does not comply. So I still expect that she did, but still has not notified the shareholders yet.
It's fun and also rewarding to see shorts getting squeezed. After all the damage they do to companies and shareholders. And how they taunt shareholders and bash CEOs. Take perfectly good plays and call them scams, all the while they are the cause of the decline. Want to see that happen here, really big!🤣
This reminds me of Sonendo S O N X that got delisted from NYSE, it dropped to .045 around December 14th and on December 26th it ran up to .40 that is 8.75x.045= close enough to .40
JAGX could very well repeat this .0512x8.75=.448
The share cancelation alone can get us to .001+ , many people loading before this really catches on. One day we should see over a billions in volume and start it running.
Very good point.
This situation might even be a strategic maneuver to ensnare short sellers
As long as the company knows how the appeal process works, and do it (again), delisting wont be an issue. Jaguar has too much riding on this to let that happen. They can't afford to let their Nasdaq listing slip away. I think today after hours, my thoughts anyway.
Jagx stock now changing paper hands, lol.
All people want to talk about is delisting or not, I guess people don't care about the fact that the company can turn everything around with (expected) positive results from the 3 month long phase 3 trial. Panic selling indeed, this is all a game to some people that serious people don't want to play, but are forced to feel the effects.
He asked, so I answered. DD Amanda usually is early picking winners. Everyone who did their DD realizes the potential here. But the rest of the market seems to need someone to tell them what to buy, so we wait till that someone tells them to buy JAGX! But it's no secret to us.
Now you let the secret out.
DD Amanda has some great results.
I usually am way early on these stocks but that is ok because i am holding a large position.
This looks like shares are getting into well known posters here. I can only keep holding strong here with all these new posters.
Maybe they can catch the SHORTS
#1 Stock Screener and Scanner: DDAmanda - NYSE, Nasdaq, OTC.
https://ddamanda.com/
The risk/reward-price/potential is too hard to pass up at this level. Looks like JAGX has been on every one's radar. And once the results get evaluated by analysts, JAGX's sentiment will change drastically to BULLISH! The time is drawing near.
Wow we have been getting some big name posters here. Glad to see you and others posting
Do you think this will go back into the trips? How low?
Shorts make money pushing stocks down, cover low and then they let it run and make money on the way back up. I fully expected this to come down to these levels and then run back up. How far up depends on other conditions, like market reaction to the results announcement and how many influencers are pumping this, and which ones traders follow the most. If conditions are right JAGX could see 100% to 1000% increase. Hope for the best!
$JAGX upon positive data JAGX becomes an instant $1b buyout candidate. Forget all the naysayers that say it will take a long time to achieve revenue. Its Mytesi asset becomes an instant goldmine. IMO, Hold hard and long.
Have a good time and a safe return.
Found this on stocktwits. I know, don't believe what you read on social media, but sometimes you find interesting tid bits.
$JAGX jagx/napo has had big pharma looking at it since inception. Valeant and salix were who got Fulyzaq/crofelemer on its feet. Valeant, now known as Bausch ownes Salix. We won rights back to Fulyzaq just before the Bausch take over. Knight therputics, Redhill, Genentech, Puma, Valeant, all wanted their hands on what is now called Mytesi.
$JAGX being BULLISH is easy. Both Puma Biotech, and Genentech Roche have documented data proving that Mytesi/crofelemer Works on chemo induced diarrhea. This clinical trial will have similar data. The numbers will only be on a larger, and necessary scale to achieve the data for labeling C.I.D.
Starting to see some of the big players come back in now,
Filled some $JAGX for a swing, gon add more https://t.co/pQFL8S2oid
— 6God (@the6boomin) February 8, 2024
BTC run to $50,000 is a given, near term. You'll see OTC traders looking for BTC related stocks at a bargain price.
If volume comes in slowly a short squeeze is probably not going to happen, shorts will cover easily and avoid a squeeze. But I think in the recent trading environment a short squeeze is very likely if very large amounts of volume comes in quickly. Traders love easy fast money, and could drive this up extremely high very quickly. Some of the conditions are already in place. VERY interesting how this will play out. We shall see...
Plus JAGX will probably formulate an over the counter medication of the same drug for regular use. And add revenue that way too.
Risk/Reward to the extreme, but at this point with the FDA approval for HIV related diarrhea treatment already in place, the cancer CTD approval seems like the next logical step for the FDA. Just need the positive data to back it up. So really JAGX’s near term future depends upon these results to be proven positive with enough evidence to justify FDA approval. But it doesn’t seem like such a long shot to me.
Risk/Reward to the extreme, but at this point with the FDA approval for HIV related diarrhea treatment already in place, the cancer CTD approval seems like the next logical step for the FDA. Just need the positive data to back it up. So really JAGX’s near term future depends upon these results to be proven positive with enough evidence to justify FDA approval. But it doesn’t seem like such a long shot to me.
I'm thinking about the difference in market sentiment as it is reflected on the share price at this time, and how traders are not considering the marketing potential of a greatly needed drug about to get the positive results needed for FDA approval, when JAGX has already cornered the market. That once traders realize that potential, what affect it will have on the share price?
Game changing results on the phase 3 trial could spark a huge amount of attention for JAGX. In the medical community and financial community as well because there is no FDA approved treatment for that cancer related side effect at this time. Once the efficacy and safety is established, we should see the news travel along those lines, Creating more demand as the extent of the need for this medicine becomes realized.
$JAGX DD Phase 3 GLOBAL Trial results due any day now!
The OnTarget Study is being done in USA, Argentina, Country of Georgia, Serbia and Tiawan
Here is my research:
USA is controlled by the FDA
Argintina controlled by National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT) is the regulatory authority for food and drug safety in Argentina The ANMAT’s standards are primarily used in Argentina. However, it’s important to note that ANMAT also cooperates with international organizations and bodies, suggesting that its standards may align with international standards.
In Serbia, the Medicines and Medical Devices Agency of Serbia (ALIMS) is responsible for the regulation and approval of medicinal products. However, it’s important to note that ALIMS also cooperates with international organizations and bodies such as the European Medicines Agency (EMA). This suggests that while Serbia has its own regulatory body and standards, it also aligns with international standards,
Taiwan Food and Drug Administration and the Center For Drug Evaluation, TFDA and CDE’s standards are recognized in multi-regional clinical trial (MRCT) protocols approved by one of the 10 referenced countries: USA, UK, France, Japan, Switzerland, Canada, Australia, Sweden
Country of Georgia state registration of medicinal products in Georgia are regulated by the Ministry of Labour, Health and Social Affairs of Georgia. In accordance with the law of Georgia "On medicinal products and pharmaceutical activity", medicinal products are allowed for use in Georgia only after addition thereof to the State departmental register.
Recognition of the state registration by conducting the simplified procedure (used only for medicinal products that have been registered in countries, wherein regulatory authorities apply high quality standards, particularly EU Member States, Switzerland, UK, USA, Canada, Japan, Australia, Korea, etc.
National state registration of medicinal product within the frame of conducting the separate registration procedure.
The amount of people getting cancer in these countries:
Argentina people a year getting cancer 130,000
Serbia people a year getting cancer 49,000
Taiwan people a year getting cancer 122,000
Country of Georgia people a year getting cancer 18,900 estimated
If half of them got chemo = 159,950 people.
If 159,950 got treated with Mytesi (crofelemer) it would be a $2.3 Billion market.
That would be a steppingstone into the rest of Asia, Europe and South America.
Worldwide Treatments……………………
Now back to the USA
Each year, more than 1 million cancer patients in the United States receive chemotherapy or radiation.
It is safe to assume that not all 1 million cancer patients receiving chemo will take Mytesi (crofelmer)
The cost for Mytesi oral delayed release tablet 125 mg is around $2,600 for a supply of 60 tablets. This amount is the one month supply as testing in the OnTarget Study.
That is a 24 week study = 5.6 month supply needed = $14,560.00 for treatment.
100,000 patients a year = $1,456,000,000
250,000 patients a year = $3,640,000,000
500,000 patients a year = $7,280,000,000
As someone else mentioned:
This, if approved will not stay a little small cap priced bio stock.
FWIW JAGX is getting some recognition on the breakout boards. Currently #21, makes you wonder who knows what, and how much do they know?
New accountant, new website, hmmm? Increased movement...something happening soon, sure looks that way!
$SMCE
— Goku (@GokuOTC) January 26, 2024
New website of the new acquisition!https://t.co/5312to9O0v
This can be big.
They changed their filings to SEC Reporting.
You have to have big plans if you change your filings to be 10x harder.
Waiting for formal update from the company. pic.twitter.com/wgW0pzPzaO